Gene · 5818
Papers3,675
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,675
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacovigilance insights into antibody-drug conjugates: a multi-database analysis of adverse events in leukemia treatment. | Expert Opin Drug Saf | 2026 | 40522479 | PubTator, text mining | PubMed |
| Nectin4-targeted molecular imaging in solid tumors: Current status and future perspectives. | View (Beijing) | 2025 | 42145938 | PubTator, text mining | PubMed |
| Active monitoring vs. spontaneous reporting of antineoplastic drug-related adverse drug reactions: evidence from the Chinese hospital pharmacovigilance system. | Front Health Serv | 2025 | 41658021 | PubTator, text mining | PubMed |
| Comparative safety profiles of baricitinib and tofacitinib in the treatment of adult alopecia areata: a pharmacovigilance study based on the FAERS database. | Front Public Health | 2025 | 41602071 | PubTator, text mining | PubMed |
| Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. | Mol Med | 2025 | 41382272 | PubTator, text mining | PubMed |
| Discovery of a small molecule TLR3 agonist adjuvant. | Nat Commun | 2025 | 41339634 | PubTator, text mining | PubMed |
| Robustness in jasmonate signaling: mechanisms of concerted regulation and implications for crop improvement. | aBIOTECH | 2025 | 41312099 | PubTator, text mining | PubMed |
| Targeting pattern recognition receptors for cancer therapy: Mechanisms and strategies. | Acta Pharm Sin B | 2025 | 41311391 | PubTator, text mining | PubMed |
| Ocular toxicity events of cyclin-dependent kinase 4/6 inhibitors in breast cancer: a pharmacovigilance study based on the faers database. | Front Pharmacol | 2025 | 41282629 | PubTator, text mining | PubMed |
| Evaluation of children's needs for creating a child-friendly environment in dental hospitals and strategy study. | BMC Public Health | 2025 | 41163139 | PubTator, text mining | PubMed |
| Circadian clock proteins BMAL1 and CLOCK regulate HSV-1 entry into nerve cells through NECTIN-1. | Virol J | 2025 | 41107851 | PubTator, text mining | PubMed |
| Orchestration of plant PRR- and NLR-mediated immunity: Protein kinases and beyond. | Mol Cell | 2025 | 41106372 | PubTator, text mining | PubMed |
| Structural basis of nectin-4 recognition by the antibody-drug conjugate 9MW2821. | J Biol Chem | 2025 | 41101504 | PubTator, text mining | PubMed |
| Pharmacovigilance assessment of drug-induced aplastic anemia: analysis of the FDA adverse event reporting system. | Int J Clin Pharm | 2025 | 41021109 | PubTator, text mining | PubMed |
| Novel Strategies for Developing Next-Generation Vaccines to Combat Infectious Viral Diseases. | Vaccines (Basel) | 2025 | 41012182 | PubTator, text mining | PubMed |
| A Comparative Study on Immune Protection Efficacy: An HSV-1 Trivalent Antigen Subunit Vaccine Formulated with a Cellular Immunity-Inducing Adjuvant Versus an mRNA Vaccine. | Vaccines (Basel) | 2025 | 41012161 | PubTator, text mining | PubMed |
| Herpes simplex virus diverts CIN85 endosomal cargo for exocytosis to evade antiviral responses: a novel role for the viral immediate-early protein ICP0. | mBio | 2025 | 40990523 | PubTator, text mining | PubMed |
| Biomarkers of immune dysregulation and posttreatment inflammation in spinal muscular atrophy. | Proc Natl Acad Sci U S A | 2025 | 40986347 | PubTator, text mining | PubMed |
| Differential expression and regulation of FASLG by miR-5195/miR-3941 in age-related hearing loss. | PLoS One | 2025 | 40971385 | PubTator, text mining | PubMed |
| Oncolytic HSV-1 expressing FLT3L kills melanoma, glioblastoma, and pancreatic cancer cells in vitro and induces immunogenic cell death. | Mol Ther Oncol | 2025 | 40955425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5818/papers?page=5